Antibody-based Therapies May Trigger Brain Inflammation

by Patricia Inacio PhD | Apr 6, 2021 | Parkinsons

New research suggests that brain inflammation is the likely reason antibody-based therapies are ineffective in clinical trials for people with Parkinson’s and Alzheimer’s diseases. The findings show that the binding of the antibody to its target protein — in the case...

Inbrain Raises $16.8M to Advance ‘Intelligent’ Neurostimulator for Parkinson’s

by Patricia Inacio PhD | Apr 5, 2021 | Parkinsons

Inbrain Neuroelectronics has raised  $16.8 million in Series A financing to support moving into clinical testing a new neuromodulation device that uses computer learning to treat Parkinson’s disease and epilepsy. Electrodes for this next-generation...

NIH $5M Grant Supports Testing Computer-aided Way of Early Diagnosis

by Patricia Inacio PhD | Mar 30, 2021 | Parkinsons

The National Institutes of Health (NIH) has awarded a $5 million grant to researchers investigating whether an artificial intelligence tool might improve the accuracy of diagnosing Parkinson’s disease at its early stages. Early diagnosis is challenging due to the...

Canadian Grant to Test Fatty Molecules in Preventing Protein Toxicity in Brain

by Patricia Inacio PhD | Mar 29, 2021 | Parkinsons

A University of Alberta pharmacology professor and researcher will use a CA $1.04 million grant to investigate the potential role of fatty molecules — called gangliosides — in treating neurodegenerative diseases, including Parkinson’s disease. The grant, from the...